DK0762883T3 - Pyridylbisphosphonater til anvendelse som terapeutisk middel - Google Patents
Pyridylbisphosphonater til anvendelse som terapeutisk middelInfo
- Publication number
- DK0762883T3 DK0762883T3 DK95920122T DK95920122T DK0762883T3 DK 0762883 T3 DK0762883 T3 DK 0762883T3 DK 95920122 T DK95920122 T DK 95920122T DK 95920122 T DK95920122 T DK 95920122T DK 0762883 T3 DK0762883 T3 DK 0762883T3
- Authority
- DK
- Denmark
- Prior art keywords
- bisphosphonates
- pyridyl
- therapeutic agents
- bone diseases
- pyridinylaminomethylidene
- Prior art date
Links
- -1 Pyridyl bisphosphonates Chemical class 0.000 title abstract 2
- 229940122361 Bisphosphonate Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 208000020084 Bone disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000010191 Osteitis Deformans Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000027868 Paget disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 208000027202 mammary Paget disease Diseases 0.000 abstract 1
- 230000000010 osteolytic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9402001A SE9402001D0 (sv) | 1994-06-09 | 1994-06-09 | Pyridylbisphosphonates for use as a therapeutical agent |
| PCT/FI1995/000315 WO1995033466A1 (en) | 1994-06-09 | 1995-06-02 | Pyridylbisphosphonates for use as a therapeutical agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0762883T3 true DK0762883T3 (da) | 2002-03-11 |
Family
ID=20394303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95920122T DK0762883T3 (da) | 1994-06-09 | 1995-06-02 | Pyridylbisphosphonater til anvendelse som terapeutisk middel |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US5866556A (cs) |
| EP (1) | EP0762883B1 (cs) |
| JP (1) | JP3883137B2 (cs) |
| KR (1) | KR100363692B1 (cs) |
| CN (1) | CN1077792C (cs) |
| AT (1) | ATE208622T1 (cs) |
| AU (1) | AU691616B2 (cs) |
| BG (1) | BG63104B1 (cs) |
| BR (1) | BR9508185A (cs) |
| CZ (1) | CZ291477B6 (cs) |
| DE (1) | DE69523914T2 (cs) |
| DK (1) | DK0762883T3 (cs) |
| EE (1) | EE03475B1 (cs) |
| ES (1) | ES2162919T3 (cs) |
| HU (1) | HU228618B1 (cs) |
| IS (1) | IS1801B (cs) |
| NO (1) | NO311069B1 (cs) |
| NZ (1) | NZ287094A (cs) |
| PL (1) | PL180705B1 (cs) |
| PT (1) | PT762883E (cs) |
| RO (1) | RO119433B1 (cs) |
| RU (1) | RU2154482C2 (cs) |
| SE (1) | SE9402001D0 (cs) |
| SK (1) | SK282650B6 (cs) |
| UA (1) | UA43918C2 (cs) |
| WO (1) | WO1995033466A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003500352A (ja) * | 1999-05-21 | 2003-01-07 | ノバルティス アクチエンゲゼルシャフト | 血管形成を処置するためのビスホスホン酸の使用 |
| WO2001044258A1 (en) * | 1999-12-17 | 2001-06-21 | Ariad Pharmaceuticals, Inc. | Novel heterocycles |
| US20020132819A1 (en) * | 1999-12-17 | 2002-09-19 | Metcalf Chester A. | Novel purinse |
| US7115589B2 (en) | 1999-12-17 | 2006-10-03 | Ariad Pharmaceuticals, Inc. | Purine derivatives |
| CA2427301C (en) * | 2000-10-27 | 2009-12-22 | Schering Oy | Method for the preparation of a pharmaceutical composition, and its use |
| WO2003070169A2 (en) * | 2002-02-19 | 2003-08-28 | Ilex Products, Inc. | Aminodiphosphonate apolipoprotein e modulators |
| TW200413381A (en) * | 2002-11-04 | 2004-08-01 | Hoffmann La Roche | Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents |
| US20050010305A1 (en) * | 2003-01-28 | 2005-01-13 | Lee Francis Y. | Novel bone graft composite |
| US20050065171A1 (en) * | 2003-06-25 | 2005-03-24 | Shakespeare William C. | Substituted purine derivatives |
| JP2005060303A (ja) * | 2003-08-12 | 2005-03-10 | Sutaagen:Kk | 不動性骨粗鬆の治療または予防剤 |
| US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US447256A (en) * | 1891-02-24 | Apparatus for flashing and exhausting incandescent electric lamps | ||
| US4447256A (en) * | 1977-07-20 | 1984-05-08 | Nissan Chemical Industries, Ltd. | N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same |
| IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
| HU199151B (en) * | 1987-03-10 | 1990-01-29 | Yamanouchi Pharma Co Ltd | Process for producing bis-phosphonic acid derivatives |
| KR880011136A (ko) * | 1987-03-11 | 1988-10-26 | 모리오까 시게오 | 아졸- 아미노메틸렌 비스포스폰산 유도체 |
-
1994
- 1994-06-09 SE SE9402001A patent/SE9402001D0/xx unknown
-
1995
- 1995-02-06 UA UA97010075A patent/UA43918C2/uk unknown
- 1995-06-02 JP JP50040096A patent/JP3883137B2/ja not_active Expired - Lifetime
- 1995-06-02 WO PCT/FI1995/000315 patent/WO1995033466A1/en not_active Ceased
- 1995-06-02 KR KR1019960706991A patent/KR100363692B1/ko not_active Expired - Lifetime
- 1995-06-02 AT AT95920122T patent/ATE208622T1/de active
- 1995-06-02 EE EE9600191A patent/EE03475B1/xx unknown
- 1995-06-02 RU RU97100161/14A patent/RU2154482C2/ru active
- 1995-06-02 DE DE69523914T patent/DE69523914T2/de not_active Expired - Lifetime
- 1995-06-02 ES ES95920122T patent/ES2162919T3/es not_active Expired - Lifetime
- 1995-06-02 EP EP95920122A patent/EP0762883B1/en not_active Expired - Lifetime
- 1995-06-02 DK DK95920122T patent/DK0762883T3/da active
- 1995-06-02 RO RO96-02286A patent/RO119433B1/ro unknown
- 1995-06-02 CZ CZ19963561A patent/CZ291477B6/cs not_active IP Right Cessation
- 1995-06-02 BR BR9508185A patent/BR9508185A/pt not_active IP Right Cessation
- 1995-06-02 CN CN95193416A patent/CN1077792C/zh not_active Expired - Lifetime
- 1995-06-02 PL PL95317612A patent/PL180705B1/pl unknown
- 1995-06-02 NZ NZ287094A patent/NZ287094A/en not_active IP Right Cessation
- 1995-06-02 SK SK1572-96A patent/SK282650B6/sk not_active IP Right Cessation
- 1995-06-02 US US08/750,355 patent/US5866556A/en not_active Expired - Lifetime
- 1995-06-02 AU AU25698/95A patent/AU691616B2/en not_active Expired
- 1995-06-02 HU HU9603375A patent/HU228618B1/hu unknown
- 1995-06-02 PT PT95920122T patent/PT762883E/pt unknown
-
1996
- 1996-12-02 IS IS4392A patent/IS1801B/is unknown
- 1996-12-06 NO NO19965228A patent/NO311069B1/no not_active IP Right Cessation
-
1997
- 1997-01-06 BG BG101116A patent/BG63104B1/bg unknown
-
1998
- 1998-12-23 US US09/219,692 patent/US6083938A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94038043A (ru) | Применение замещенных производных аденина для лечения множественного склероза | |
| BG100910A (bg) | Използване на бисфосфонати за инхибиране на костна резорбция след имплантиране на ортопедична протеза | |
| DE69736441D1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| YU18400A (sh) | Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja | |
| EP1233770A4 (en) | PHOSPHONATE COMPOUNDS | |
| SE9701398D0 (sv) | Novel compounds | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| AP9200410A0 (en) | Retroviral protease inhibitors. | |
| PT998287E (pt) | Utilizacao de levobupivacaina | |
| SE8704248D0 (sv) | Medical use | |
| DK0762883T3 (da) | Pyridylbisphosphonater til anvendelse som terapeutisk middel | |
| ES2168766T3 (es) | Preparacion farmaceutica que incluye el propeptido vwf. | |
| ATE251139T1 (de) | (+)-norcisapride verwendbar bei 5-ht3 und 5-ht4 bedingten krankheiten | |
| ATE252897T1 (de) | Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| ATE238986T1 (de) | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga | |
| IS1910B (is) | Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi | |
| BR9808233A (pt) | Preparação farmacêutica | |
| SE8903529D0 (sv) | Medical use | |
| SE9303853D0 (sv) | The use of an ester of inositoltrisphosphate for the preparing of medicaments | |
| ATE330604T1 (de) | Behandlung von manischen erkrankungen | |
| MX9606180A (es) | Piridilbisfosfonatos para utilizarse como un agente terapeutico. | |
| CA2192456A1 (en) | Pyridylbisphosphonates for use as a therapeutical agent | |
| FR2613621B1 (fr) | Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants |